nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ALB—chronic obstructive pulmonary disease	0.217	1	CbGaD
Zidovudine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0758	0.142	CbGbCtD
Zidovudine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0758	0.142	CbGbCtD
Zidovudine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0575	0.108	CbGbCtD
Zidovudine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0337	0.0634	CbGbCtD
Zidovudine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0314	0.0589	CbGbCtD
Zidovudine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0314	0.0589	CbGbCtD
Zidovudine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0283	0.0532	CbGbCtD
Zidovudine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0261	0.049	CbGbCtD
Zidovudine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0261	0.049	CbGbCtD
Zidovudine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0203	0.0382	CbGbCtD
Zidovudine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.02	0.0376	CbGbCtD
Zidovudine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0198	0.0371	CbGbCtD
Zidovudine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0135	0.0254	CbGbCtD
Zidovudine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0132	0.0247	CbGbCtD
Zidovudine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0129	0.0242	CbGbCtD
Zidovudine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0115	0.0216	CbGbCtD
Zidovudine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0113	0.0211	CbGbCtD
Zidovudine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0106	0.02	CbGbCtD
Zidovudine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00674	0.0127	CbGbCtD
Zidovudine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00637	0.012	CbGbCtD
Zidovudine—TERT—respiratory system—chronic obstructive pulmonary disease	0.00205	0.219	CbGeAlD
Zidovudine—TERT—connective tissue—chronic obstructive pulmonary disease	0.00181	0.193	CbGeAlD
Zidovudine—TK1—respiratory system—chronic obstructive pulmonary disease	0.00141	0.151	CbGeAlD
Zidovudine—TERT—lung—chronic obstructive pulmonary disease	0.00109	0.116	CbGeAlD
Zidovudine—TK1—lung—chronic obstructive pulmonary disease	0.00075	0.0801	CbGeAlD
Zidovudine—ABCC5—bronchus—chronic obstructive pulmonary disease	0.000519	0.0554	CbGeAlD
Zidovudine—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00036	0.0384	CbGeAlD
Zidovudine—ABCC5—lung—chronic obstructive pulmonary disease	0.000335	0.0358	CbGeAlD
Zidovudine—CYP2A6—lung—chronic obstructive pulmonary disease	0.0003	0.0321	CbGeAlD
Zidovudine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00164	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00164	CcSEcCtD
Zidovudine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00164	CcSEcCtD
Zidovudine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00164	CcSEcCtD
Zidovudine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00162	CcSEcCtD
Zidovudine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00162	CcSEcCtD
Zidovudine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000264	0.0016	CcSEcCtD
Zidovudine—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000264	0.0016	CcSEcCtD
Zidovudine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.0016	CcSEcCtD
Zidovudine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00159	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00159	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00159	CcSEcCtD
Zidovudine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00159	CcSEcCtD
Zidovudine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00158	CcSEcCtD
Zidovudine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00158	CcSEcCtD
Zidovudine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00156	CcSEcCtD
Zidovudine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00156	CcSEcCtD
Zidovudine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00156	CcSEcCtD
Zidovudine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00156	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00155	CcSEcCtD
Zidovudine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00155	CcSEcCtD
Zidovudine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00155	CcSEcCtD
Zidovudine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00153	CcSEcCtD
Zidovudine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00153	CcSEcCtD
Zidovudine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00153	CcSEcCtD
Zidovudine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00153	CcSEcCtD
Zidovudine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00151	CcSEcCtD
Zidovudine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00151	CcSEcCtD
Zidovudine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00151	CcSEcCtD
Zidovudine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00151	CcSEcCtD
Zidovudine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.0015	CcSEcCtD
Zidovudine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.0015	CcSEcCtD
Zidovudine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000248	0.0015	CcSEcCtD
Zidovudine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.0015	CcSEcCtD
Zidovudine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000247	0.0015	CcSEcCtD
Zidovudine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000247	0.0015	CcSEcCtD
Zidovudine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00149	CcSEcCtD
Zidovudine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00149	CcSEcCtD
Zidovudine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00149	CcSEcCtD
Zidovudine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00147	CcSEcCtD
Zidovudine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00147	CcSEcCtD
Zidovudine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00146	CcSEcCtD
Zidovudine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Zidovudine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Zidovudine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00143	CcSEcCtD
Zidovudine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00142	CcSEcCtD
Zidovudine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00142	CcSEcCtD
Zidovudine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00142	CcSEcCtD
Zidovudine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00142	CcSEcCtD
Zidovudine—ABCC4—lung—chronic obstructive pulmonary disease	0.000232	0.0248	CbGeAlD
Zidovudine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.0014	CcSEcCtD
Zidovudine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.0014	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00139	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00139	CcSEcCtD
Zidovudine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00138	CcSEcCtD
Zidovudine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00138	CcSEcCtD
Zidovudine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00138	CcSEcCtD
Zidovudine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.00138	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00137	CcSEcCtD
Zidovudine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00136	CcSEcCtD
Zidovudine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00136	CcSEcCtD
Zidovudine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00136	CcSEcCtD
Zidovudine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00136	CcSEcCtD
Zidovudine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00136	CcSEcCtD
Zidovudine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00135	CcSEcCtD
Zidovudine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00135	CcSEcCtD
Zidovudine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00135	CcSEcCtD
Zidovudine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00135	CcSEcCtD
Zidovudine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00134	CcSEcCtD
Zidovudine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00133	CcSEcCtD
Zidovudine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00133	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00132	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00132	CcSEcCtD
Zidovudine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00132	CcSEcCtD
Zidovudine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00132	CcSEcCtD
Zidovudine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00132	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00132	CcSEcCtD
Zidovudine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00131	CcSEcCtD
Zidovudine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00131	CcSEcCtD
Zidovudine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00131	CcSEcCtD
Zidovudine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00131	CcSEcCtD
Zidovudine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00131	CcSEcCtD
Zidovudine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.0013	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00129	CcSEcCtD
Zidovudine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00129	CcSEcCtD
Zidovudine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00129	CcSEcCtD
Zidovudine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00129	CcSEcCtD
Zidovudine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00128	CcSEcCtD
Zidovudine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00128	CcSEcCtD
Zidovudine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00127	CcSEcCtD
Zidovudine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00127	CcSEcCtD
Zidovudine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00127	CcSEcCtD
Zidovudine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00127	CcSEcCtD
Zidovudine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00126	CcSEcCtD
Zidovudine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00126	CcSEcCtD
Zidovudine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000208	0.00126	CcSEcCtD
Zidovudine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00126	CcSEcCtD
Zidovudine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00125	CcSEcCtD
Zidovudine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00125	CcSEcCtD
Zidovudine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00125	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00125	CcSEcCtD
Zidovudine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00125	CcSEcCtD
Zidovudine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00124	CcSEcCtD
Zidovudine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00124	CcSEcCtD
Zidovudine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00123	CcSEcCtD
Zidovudine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00122	CcSEcCtD
Zidovudine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00122	CcSEcCtD
Zidovudine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00121	CcSEcCtD
Zidovudine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00121	CcSEcCtD
Zidovudine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00121	CcSEcCtD
Zidovudine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00121	CcSEcCtD
Zidovudine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00121	CcSEcCtD
Zidovudine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00121	CcSEcCtD
Zidovudine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.0012	CcSEcCtD
Zidovudine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00119	CcSEcCtD
Zidovudine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000197	0.00119	CcSEcCtD
Zidovudine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00119	CcSEcCtD
Zidovudine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00119	CcSEcCtD
Zidovudine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00119	CcSEcCtD
Zidovudine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00119	CcSEcCtD
Zidovudine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00119	CcSEcCtD
Zidovudine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00118	CcSEcCtD
Zidovudine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00117	CcSEcCtD
Zidovudine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00116	CcSEcCtD
Zidovudine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00115	CcSEcCtD
Zidovudine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00114	CcSEcCtD
Zidovudine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00114	CcSEcCtD
Zidovudine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00113	CcSEcCtD
Zidovudine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.0011	CcSEcCtD
Zidovudine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.0011	CcSEcCtD
Zidovudine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00108	CcSEcCtD
Zidovudine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00108	CcSEcCtD
Zidovudine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00108	CcSEcCtD
Zidovudine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00106	CcSEcCtD
Zidovudine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00105	CcSEcCtD
Zidovudine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00105	CcSEcCtD
Zidovudine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00104	CcSEcCtD
Zidovudine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00104	CcSEcCtD
Zidovudine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00103	CcSEcCtD
Zidovudine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00103	CcSEcCtD
Zidovudine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00102	CcSEcCtD
Zidovudine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00102	CcSEcCtD
Zidovudine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00101	CcSEcCtD
Zidovudine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00101	CcSEcCtD
Zidovudine—ABCG2—lung—chronic obstructive pulmonary disease	0.000164	0.0175	CbGeAlD
Zidovudine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000992	CcSEcCtD
Zidovudine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000991	CcSEcCtD
Zidovudine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000989	CcSEcCtD
Zidovudine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000973	CcSEcCtD
Zidovudine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000973	CcSEcCtD
Zidovudine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000965	CcSEcCtD
Zidovudine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000965	CcSEcCtD
Zidovudine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000964	CcSEcCtD
Zidovudine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000964	CcSEcCtD
Zidovudine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000959	CcSEcCtD
Zidovudine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000959	CcSEcCtD
Zidovudine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000959	CcSEcCtD
Zidovudine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000956	CcSEcCtD
Zidovudine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000953	CcSEcCtD
Zidovudine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000945	CcSEcCtD
Zidovudine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000945	CcSEcCtD
Zidovudine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000943	CcSEcCtD
Zidovudine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000939	CcSEcCtD
Zidovudine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000928	CcSEcCtD
Zidovudine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000926	CcSEcCtD
Zidovudine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000152	0.0163	CbGeAlD
Zidovudine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000919	CcSEcCtD
Zidovudine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000916	CcSEcCtD
Zidovudine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000913	CcSEcCtD
Zidovudine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000911	CcSEcCtD
Zidovudine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000911	CcSEcCtD
Zidovudine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000911	CcSEcCtD
Zidovudine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000909	CcSEcCtD
Zidovudine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000909	CcSEcCtD
Zidovudine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000906	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000893	CcSEcCtD
Zidovudine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000891	CcSEcCtD
Zidovudine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.00088	CcSEcCtD
Zidovudine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000859	CcSEcCtD
Zidovudine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000855	CcSEcCtD
Zidovudine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000833	CcSEcCtD
Zidovudine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000829	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000829	CcSEcCtD
Zidovudine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000816	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000802	CcSEcCtD
Zidovudine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00075	CcSEcCtD
Zidovudine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000744	CcSEcCtD
Zidovudine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000743	CcSEcCtD
Zidovudine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000738	CcSEcCtD
Zidovudine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000738	CcSEcCtD
Zidovudine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000709	CcSEcCtD
Zidovudine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000685	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000683	CcSEcCtD
Zidovudine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000682	CcSEcCtD
Zidovudine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000112	0.012	CbGeAlD
Zidovudine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000675	CcSEcCtD
Zidovudine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000666	CcSEcCtD
Zidovudine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000663	CcSEcCtD
Zidovudine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000662	CcSEcCtD
Zidovudine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000659	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000649	CcSEcCtD
Zidovudine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00064	CcSEcCtD
Zidovudine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000628	CcSEcCtD
Zidovudine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000628	CcSEcCtD
Zidovudine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000626	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000624	CcSEcCtD
Zidovudine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000621	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.000602	CcSEcCtD
Zidovudine—Oedema—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.000602	CcSEcCtD
Zidovudine—Shock—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000593	CcSEcCtD
Zidovudine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000591	CcSEcCtD
Zidovudine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000585	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000582	CcSEcCtD
Zidovudine—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000574	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000549	CcSEcCtD
Zidovudine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.000548	CcSEcCtD
Zidovudine—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000545	CcSEcCtD
Zidovudine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000541	CcSEcCtD
Zidovudine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.00053	CcSEcCtD
Zidovudine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000524	CcSEcCtD
Zidovudine—Rash—Prednisolone—chronic obstructive pulmonary disease	8.62e-05	0.000523	CcSEcCtD
Zidovudine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000522	CcSEcCtD
Zidovudine—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000519	CcSEcCtD
Zidovudine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.56e-05	0.000519	CcSEcCtD
Zidovudine—Constipation—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000515	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000496	CcSEcCtD
Zidovudine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000493	CcSEcCtD
Zidovudine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.12e-05	0.000492	CcSEcCtD
Zidovudine—ABCB1—lung—chronic obstructive pulmonary disease	8.08e-05	0.00863	CbGeAlD
Zidovudine—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000479	CcSEcCtD
Zidovudine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000476	CcSEcCtD
Zidovudine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000476	CcSEcCtD
Zidovudine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000432	CcSEcCtD
Zidovudine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000426	CcSEcCtD
Zidovudine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000412	CcSEcCtD
Zidovudine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000398	CcSEcCtD
Zidovudine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000383	CcSEcCtD
Zidovudine—Rash—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.00038	CcSEcCtD
Zidovudine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.00038	CcSEcCtD
Zidovudine—Headache—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000377	CcSEcCtD
Zidovudine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000358	CcSEcCtD
Zidovudine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.0005	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.83e-05	0.000499	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.83e-05	0.000499	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.75e-05	0.000488	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.75e-05	0.000488	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.75e-05	0.000488	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.75e-05	0.000487	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.72e-05	0.000484	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.71e-05	0.000483	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.000481	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.67e-05	0.000478	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KL—chronic obstructive pulmonary disease	3.65e-05	0.000476	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.64e-05	0.000474	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.63e-05	0.000472	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	3.61e-05	0.000469	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.57e-05	0.000465	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.56e-05	0.000463	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.55e-05	0.000462	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.00046	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.51e-05	0.000457	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.000456	CbGpPWpGaD
Zidovudine—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.49e-05	0.000454	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.45e-05	0.000449	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.44e-05	0.000448	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.43e-05	0.000447	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.4e-05	0.000443	CbGpPWpGaD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.4e-05	0.000442	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.39e-05	0.000441	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.37e-05	0.000439	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.35e-05	0.000436	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.32e-05	0.000432	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.31e-05	0.000431	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.3e-05	0.00043	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.28e-05	0.000427	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.27e-05	0.000426	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.27e-05	0.000426	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.26e-05	0.000424	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.25e-05	0.000423	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.000419	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000414	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.13e-05	0.000408	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.13e-05	0.000407	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.08e-05	0.000401	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.06e-05	0.000398	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.06e-05	0.000398	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.05e-05	0.000396	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.02e-05	0.000394	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.98e-05	0.000387	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.95e-05	0.000384	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.92e-05	0.00038	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.91e-05	0.000378	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.89e-05	0.000376	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.88e-05	0.000374	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.86e-05	0.000372	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.85e-05	0.000371	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.84e-05	0.00037	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.84e-05	0.00037	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFB1—chronic obstructive pulmonary disease	2.76e-05	0.000359	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.75e-05	0.000358	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000358	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	2.74e-05	0.000356	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.71e-05	0.000353	CbGpPWpGaD
Zidovudine—TERT—Disease—EGFR—chronic obstructive pulmonary disease	2.7e-05	0.000352	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.00035	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.68e-05	0.000348	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000345	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.63e-05	0.000342	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.6e-05	0.000339	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.59e-05	0.000337	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.55e-05	0.000331	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.5e-05	0.000326	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.49e-05	0.000325	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.49e-05	0.000324	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000323	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000321	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000317	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.42e-05	0.000315	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.4e-05	0.000313	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.4e-05	0.000312	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.38e-05	0.00031	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000308	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.34e-05	0.000305	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000305	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.32e-05	0.000303	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.31e-05	0.000301	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000301	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.0003	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.3e-05	0.000299	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000298	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	2.28e-05	0.000297	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.26e-05	0.000294	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.25e-05	0.000293	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000291	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.1e-05	0.000274	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.1e-05	0.000274	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.09e-05	0.000272	CbGpPWpGaD
Zidovudine—TERT—Disease—IL6—chronic obstructive pulmonary disease	2.08e-05	0.00027	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-05	0.00027	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.07e-05	0.00027	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000268	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.04e-05	0.000265	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.03e-05	0.000264	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.000263	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2e-05	0.00026	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000259	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.97e-05	0.000257	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.97e-05	0.000256	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.97e-05	0.000256	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000256	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.95e-05	0.000253	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.93e-05	0.000251	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.92e-05	0.00025	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.89e-05	0.000246	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.89e-05	0.000246	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.89e-05	0.000246	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.88e-05	0.000245	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-05	0.000244	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.88e-05	0.000244	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.84e-05	0.00024	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.84e-05	0.000239	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000239	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.83e-05	0.000238	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.81e-05	0.000235	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000234	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.79e-05	0.000233	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.79e-05	0.000233	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.78e-05	0.000231	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.74e-05	0.000227	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000227	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.74e-05	0.000226	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.73e-05	0.000225	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.71e-05	0.000223	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000218	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.000217	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.66e-05	0.000216	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000215	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.64e-05	0.000214	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.64e-05	0.000213	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.64e-05	0.000213	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.63e-05	0.000212	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.61e-05	0.00021	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000209	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.59e-05	0.000207	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.57e-05	0.000204	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.0002	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.53e-05	0.000199	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.5e-05	0.000196	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.5e-05	0.000196	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000195	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.48e-05	0.000193	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.47e-05	0.000192	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.46e-05	0.000189	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.43e-05	0.000186	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.4e-05	0.000183	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.00018	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000178	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000177	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000177	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000175	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.000165	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000163	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	0.000163	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.25e-05	0.000162	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.25e-05	0.000162	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000161	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000161	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000161	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.23e-05	0.00016	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.22e-05	0.000159	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	0.000158	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	1.21e-05	0.000158	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000158	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000156	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000155	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.19e-05	0.000155	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000155	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000154	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.15e-05	0.00015	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000148	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000148	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.13e-05	0.000147	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.000144	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000144	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	0.000142	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000142	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.00014	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000138	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000134	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.000133	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000132	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.000131	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.95e-06	0.000129	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.94e-06	0.000129	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.71e-06	0.000126	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.43e-06	0.000123	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.27e-06	0.000121	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.17e-06	0.000119	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	9.15e-06	0.000119	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.07e-06	0.000118	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.95e-06	0.000116	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.57e-06	0.000112	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.56e-06	0.000111	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.52e-06	0.000111	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.45e-06	0.00011	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.4e-06	0.000109	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.36e-06	0.000109	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	8.17e-06	0.000106	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	8.09e-06	0.000105	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.87e-06	0.000102	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.87e-06	0.000102	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.83e-06	0.000102	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.82e-06	0.000102	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.74e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.64e-06	9.95e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.54e-06	9.81e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.46e-06	9.71e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.46e-06	9.71e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.42e-06	9.66e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.42e-06	9.65e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.36e-06	9.58e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.1e-06	9.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.02e-06	9.14e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.97e-06	9.07e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.87e-06	8.95e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.86e-06	8.92e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.66e-06	8.67e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.63e-06	8.63e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.56e-06	8.53e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.5e-06	8.46e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.48e-06	8.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.41e-06	8.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.07e-06	7.9e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.98e-06	7.78e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.51e-06	7.17e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.07e-06	6.6e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.85e-06	6.31e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.82e-06	6.28e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.6e-06	5.98e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.53e-06	5.9e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.53e-06	5.89e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.42e-06	5.75e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.33e-06	5.63e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.23e-06	5.5e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.22e-06	5.5e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.13e-06	5.37e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4e-06	5.21e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	5.14e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	3.54e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	3.39e-05	CbGpPWpGaD
